Resource: Toni Barros/Wikimedia
Cellular Reprogramming, revealed by Mary Ann Liebert, Inc., is dedicated to offering new insights on the etiology, development, and likely therapy of numerous diseases by means of reprogramming cellular mechanisms. The Journal provides data on reducing-edge methods and the newest high-quality analysis and discoveries that are transforming biomedical analysis. The over write-up was first printed in the February 2018 concern of Cellular Reprogramming with the title “Cloning After Dolly”. The sights expressed right here are individuals of the authors and are not automatically these of Stem Cells and Development, Mary Ann Liebert, Inc., publishers, or their affiliate marketers. No endorsement of any entity or technology is implied.
To get pleasure from much more articles or blog posts like this from GEN,
simply click below to subscribe now!